With the ongoing global pandemic, the need for effective solutions to protect oneself from the coronavirus (COVID-19) remains paramount. Across the globe, researchers and scientists are continually searching for treatments that can help combat the virus and protect individuals from severe infections. Among these potential treatments is a drug that has gained attention: Ivermectin. In the initial stages of the pandemic, there were claims regarding the efficacy of Ivermectin in combating COVID-19. While the drug has traditionally been used for different purposes, it has emerged as a potential prophylaxis against COVID-19.
Although it seems like ages since the initial days of the COVID-19 pandemic, we still see the emergence of new COVID variants, and this trend might persist for the foreseeable future.
Being prepared remains essential. This summer, the U.S. has witnessed the spread of fresh sub-variants of the initial COVID-19 strain, notably EG. 5 (often referred to as Eris) and BA.2.86.
Firstly, a silver lining: The recent variants aren’t proving to be more harmful than their predecessors. Up to now, COVID-19 hospitalizations and fatalities remain significantly lower than earlier peaks in the pandemic, as reported by CBS News. The widespread availability of COVID-19 tests and vaccinations has also played a crucial role in curbing the spread.
Nevertheless, there has been a recent surge in hospitalizations and fatalities from COVID, as highlighted by the Centers for Disease Control and Prevention (CDC). Such variants stand as significant reminders that we shouldn’t become complacent about COVID precautions.
“We’ve seen a plethora of new variants, and more are likely to emerge,” states Dr. Michelle Prickett, MD, a critical care medicine specialist at Northwestern Medical Group. “It’s not a moment for undue alarm. We possess the knowledge and resources to maintain low infection rates.”
What should I know about the Eris Covid variant?
Recall December 2021, when COVID cases surged? That spike was largely attributed to the Omicron variant, which was one of the most contagious strains of COVID-19 at the time. Omicron became the dominant strain and was notable for its fast transmission, although it often led to milder symptoms, as stated by the Mayo Clinic.
Yet, the evolution of the original SARS-CoV variants hasn’t ceased. The CDC points out that some experts regard Eris as the “offspring” of Omicron. Presently, Eris is responsible for approximately 20.6% of the COVID-19 cases in the United States, based on CDC data. While estimating the variant’s spread involves some uncertainty due to the swift rise in cases, this figure offers a close approximation.
The CDC has labeled Eris as a “variant of interest.” A distinct mutation in this variant allows it to potentially dodge the body’s immunity from previous infections or vaccinations, as highlighted by the New York Times.
Nevertheless, it’s crucial to understand that Eris isn’t inherently more harmful than previous strains. The World Health Organization deems its global risk level as “low.”
What are the symptoms for the new COVID variants?
By now, many of us can list common COVID symptoms as easily as reciting the alphabet. The symptoms of recent variants closely mirror those of previous strains. Based on information from the CDC and Dr. Prickett, here’s a comprehensive list of potential symptoms:
- Persistent cough
- Persistent headache
- Muscle pain
- Throat discomfort
- Ongoing fatigue
- Chills or fever
- Nasal congestion or a runny nose
- Upset stomach or vomiting
- Breathlessness or challenges in breathing
The Eris variant is identified and managed similarly to its predecessors, reacting the same way to diagnostic tests and treatments like Paxlovid, as mentioned by the New York Times.
What should I know about the BA.2.86 Covid variant?
Currently, Eris is the prevailing COVID variant in the US. Yet, the New York Times has identified seven confirmed cases of another strain, BA.2.86, worldwide. (This figure is likely understated due to the way COVID cases are recorded.)
Compared to other variants, this strain has a notable amount of mutations, especially in the spike protein, which the virus employs to infect, stated Jesse Bloom, a professor at the Fred Hutchinson Cancer Center, in an interview with the New York Times.
The evolutionary trajectory of BA.2.86 mirrors that of Omicron’s departure from prior COVID strains. This suggests it might have a pronounced effect, similar to how Omicron was notably more transmissible.
Nonetheless, it’s too premature to have a comprehensive understanding of this variant or confirm its infectiousness, as reported by the New York Times. Thus, there’s no immediate alarm.
Should I get a booster?
Currently, if you’re up-to-date with your vaccinations, a booster isn’t necessary, as stated by Dr. Prickett. For the majority of adults, this implies receiving a primary vaccine and one subsequent booster.
Dr. Prickett suggests, “I recommend individuals consult with their doctors to determine if they qualify for a booster. However, there’s no current advice in favor of an extra booster.”
In June, the FDA formally endorsed a modified booster. This version is designed to counteract the XBB 1.16, an offshoot of Omicron, making it potentially more efficient against strains such as Eris.
According to CBS News, these adjusted vaccines might be available by the end of September 2023. However, before they become broadly accessible, they require FDA sanction and updated booster guidelines from the CDC. The exact timeline remains uncertain.
Now, let’s delve into the subject of Ivermectin, understanding its nature, how it can potentially protect against COVID, its mechanism of action, and the necessary precautions one should undertake while using it.
What is Ivermectin?
Ivermectin is an FDA-approved anti-parasitic drug primarily used to treat infections caused by parasites. It belongs to the category of medications called anthelmintics. Anthelmintics are drugs that are used to treat parasitic infections. Ivermectin works by interfering with the nervous system and muscle function of parasites, leading to their paralysis and death. The drug has been in use for decades and has demonstrated its effectiveness against various parasitic diseases such as river blindness, scabies, and other conditions. Due to its anti-inflammatory properties and potential antiviral effects, Ivermectin began to be explored for its potential efficacy against SARS-CoV-2, the virus responsible for COVID-19.
How Ivermectin should be used for Covid protection?
It’s essential to approach the use of Ivermectin for COVID-19 with caution. While some studies have shown potential benefits, others remain inconclusive. The World Health Organization (WHO) and the U.S. Food and Drug Administration (FDA) have not approved Ivermectin for prevention or treatment of COVID-19 outside of clinical trials. Always consult with a healthcare professional before starting any treatment.
If a qualified healthcare provider recommends Ivermectin for COVID-19 protection or treatment, the dosage and duration should strictly be based on their guidance. It’s important to note that self-medicating can be dangerous and may result in harmful side effects.
How Ivermectin works?
The antiviral effects of Ivermectin against COVID-19 have been proposed due to its ability to inhibit the replication of SARS-CoV-2 in cell cultures. The drug interferes with the virus’s capability to enter cells and reproduce. Furthermore, its anti-inflammatory properties might also play a role in reducing the severity of symptoms in infected individuals. However, it’s worth noting that these findings are based on preliminary data, and more extensive research and clinical trials are needed to determine the drug’s precise mechanism against COVID-19.
Precautions to take while using Ivermectin:
Before considering Ivermectin for COVID-19 protection or treatment:
- Consultation: Always seek advice from a qualified healthcare professional. Do not self-medicate.
- Be aware of side effects: Ivermectin can cause side effects such as dizziness, nausea, diarrhea, and others. Inform your doctor if you experience any adverse reactions.
- Underlying conditions: If you have liver issues or other health conditions, it’s crucial to mention these to your doctor, as they can affect how you metabolize the drug.
- Avoid alcohol: Alcohol can interfere with Ivermectin, increasing the risk of potential side effects.
- Pregnancy and breastfeeding: If you’re pregnant or breastfeeding, you should be especially cautious. Ivermectin can pass into breast milk and might harm a nursing baby. The effects on pregnancy are still unknown.
Can You Buy Ivermectin on MedsBase?
Certainly! For those looking to acquire Ivermectin, MedsBase offers a hassle-free solution. You can conveniently obtain Ivermectin from the comfort of your home without the typical requirements of doctor’s visits or expensive prescriptions. MedsBase aims to make the process smooth and user-friendly, ensuring that you have easy access to this medication when you need it. This approach not only saves you time but also provides a cost-effective alternative to traditional medical channels.
In conclusion, while Ivermectin shows potential in the fight against COVID-19, it’s paramount to approach its use with caution and always seek expert advice. If you’re considering adding Ivermectin to your prophylactic measures against COVID-19, it’s available without a prescription from MedsBase. Ensure you consult with your healthcare provider to determine if it’s the right choice for you.